Page last updated: 2024-08-21

2-anthramine and Glioblastoma with Sarcomatous Component

2-anthramine has been researched along with Glioblastoma with Sarcomatous Component in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breakefield, XO; Chiocca, EA; Dobberstein, KU; Herrlinger, U; Hilton, J; Kramm, CM; Philpot, RM; Rainov, NG; Sena-Esteves, M	1
Fischer, U; Frank, S; Kramm, CM; Rainov, NG; Steffens, S; Tlolko, A	1

Other Studies

2 other study(ies) available for 2-anthramine and Glioblastoma with Sarcomatous Component

Article	Year
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Human gene therapy, 1998, Jun-10, Volume: 9, Issue:9 Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Brain Neoplasms; Culture Media, Conditioned; Cytochrome P-450 Enzyme System; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Genetic Therapy; Glioblastoma; Gliosarcoma; Glutathione; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Plasmids; Prodrugs; Rabbits; Rats; Terpenes; Transfection; Tumor Cells, Cultured	1998
Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy. Cancer gene therapy, 2002, Volume: 9, Issue:2 Topics: Animals; Anthracenes; Antiviral Agents; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Bystander Effect; Cell Cycle; Cell Survival; Cytochrome P-450 Enzyme System; Flow Cytometry; Ganciclovir; Genetic Therapy; Gliosarcoma; Green Fluorescent Proteins; Herpesvirus 1, Human; Humans; Luminescent Proteins; Pharmacogenetics; Prodrugs; Rabbits; Terpenes; Thymidine Kinase; Transfection; Tumor Cells, Cultured	2002

Article

Year

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.

Human gene therapy, 1998, Jun-10, Volume: 9, Issue:9

Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Brain Neoplasms; Culture Media, Conditioned; Cytochrome P-450 Enzyme System; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Genetic Therapy; Glioblastoma; Gliosarcoma; Glutathione; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Plasmids; Prodrugs; Rabbits; Rats; Terpenes; Transfection; Tumor Cells, Cultured

1998

Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.

Cancer gene therapy, 2002, Volume: 9, Issue:2

Topics: Animals; Anthracenes; Antiviral Agents; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Bystander Effect; Cell Cycle; Cell Survival; Cytochrome P-450 Enzyme System; Flow Cytometry; Ganciclovir; Genetic Therapy; Gliosarcoma; Green Fluorescent Proteins; Herpesvirus 1, Human; Humans; Luminescent Proteins; Pharmacogenetics; Prodrugs; Rabbits; Terpenes; Thymidine Kinase; Transfection; Tumor Cells, Cultured

2002